Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aclarion Inc ACON

Healthcare Medical Devices
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the... see more

Recent & Breaking News (NDAQ:ACON)

Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI

GlobeNewswire June 14, 2023

Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting

GlobeNewswire June 8, 2023

Aclarion Announces New Engagement with The London Clinic and London Spine Clinic

GlobeNewswire May 30, 2023

Aclarion's Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD

GlobeNewswire May 23, 2023

Aclarion, Inc. Announces Delayed 10-Q Filing

GlobeNewswire May 23, 2023

Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts

GlobeNewswire May 19, 2023

Aclarion Appoints Nicholas Theodore, MD as Principal Investigator for CLARITY Post-Market Trial Evaluating Nociscan in the Diagnosis and Treatment of Chronic Low Back Pain

GlobeNewswire May 2, 2023

Aclarion to Host Thought Leadership Symposium at SPINEWEEK 2023

GlobeNewswire April 28, 2023

Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial

GlobeNewswire April 24, 2023

Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor

GlobeNewswire March 7, 2023

Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposium

GlobeNewswire February 15, 2023

Gregory Basil MD to Join Aclarion as a Key Opinion Leader Surgeon Advisor 

GlobeNewswire January 31, 2023

Aclarion Appoints George Frey MD as Seventh Key Opinion Leader Surgeon Advisor

GlobeNewswire January 17, 2023

Aclarion to Present at the Jan 26th Virtual Investor Summit Microcap Event

Newsfile January 17, 2023

Dr. Christopher Ames to Join Aclarion as a Key Opinion Leader Surgeon Advisor

GlobeNewswire December 22, 2022

Aclarion's Key Opinion Leader Program Adds Fifth Surgeon Advisor with Addition of Eric Potts, MD

GlobeNewswire December 21, 2022

Aclarion Adds to Growing Key Opinion Leader Program with Juan Uribe M.D. as a Surgeon Advisor

GlobeNewswire December 19, 2022

Aclarion Adds to Strong Patent Portfolio with Notice of Allowance for New U.S. Patent Application Addressing Key Pain Indicator Biomarker

GlobeNewswire December 1, 2022

Aclarion, Inc. Releases Updated Investor Presentation In Connection with Appearance at LD Micro Main Event XV

Accesswire October 25, 2022

Dr. Sigurd Berven to join Aclarion as a Key Opinion Leader Surgeon Advisor

Accesswire October 24, 2022